Clinical Trial Results:
A Randomized Phase II Biomarker Neoadjuvant Study of Sequential AC Followed by
Ixabepilone Compared to Sequential AC Followed by Paclitaxel in Women with Early
Stage Breast Cancer Not Overexpressing HER-2 and Estrogen Receptors.
And Pharmacogenetics Blood Sample Amendment 01 - Site Specific (Version 1.0, Date 21-Dec-2006).
Summary
|
|
EudraCT number |
2006-003047-24 |
Trial protocol |
FR ES IT GB DE AT |
Global completion date |
14 Dec 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Dec 2016
|
First version publication date |
28 Dec 2016
|
Other versions |
|
Summary report(s) |
CA163-100_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.